It wasn’t a discussion with Les, but rather with Dave. And I don’t think any of the SAB guys have written text books on FDA regs, so I haven’t any link to the person as I don’t know who it is. Anyhow, I was simply responding to your comment about specialists and the role they might play in this trial.
Market Data 
Markets 
AI
